Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124959) titled 'A Clinical Study of Organoid-Guided Drug Sensitivity Testing for Second-Line Therapy in Metastatic Urothelial Carcinoma' on May 19.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The First Affiliated Hospital of Ningbo University

Condition: Metastatic urothelial carcinoma

Recruitment Status: Not Recruiting

Phase: 0

Date of First Enrollment: 2026-05-31

Target Sample Size: Experimental group:19;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=319149

Published by HT Digital Content Services with permission from Health Daily D...